Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip +7 more— 510(k) K261008

Substantially Equivalent

Stryker Spine

FDA 510(k) clearance K261008 for Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip +7 more, Substantially Equivalent on 2026-04-24. Applicant: Stryker Spine. Device class: 2.

Summary

Stryker Spine's record lists nine Vitoss products, each named as a bone graft substitute, among them BiModal, BBTrauma, and BA2X versions. All nine are filed under product code MQV (Filler, Bone Void, Calcium Compound).

Class II, 21 CFR 888.3045. It came in as a Special 510(k), and Orthopedic is both the classification panel and the review panel.

Stryker Spine filed from Allendale, New Jersey. Review took 29 calendar days (March 26 to April 24, 2026).

Clearance details

Device name as filed
Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip; Vitoss® BiModal Bioactive Bone Graft Substitute; Vitoss BBTrauma® Bioactive Bone Graft Substitute; Vitoss® BA2X Bioactive Bone Graft Substitute; Vitoss® Bioactive Foam Bone Graft Substitute Pack; Vitoss® Bioactive Foam Bone Graft Substitute; Vitoss® Foam Bone Graft Substitute; Vitoss® Bone Graft Substitute Filled Canister; Vitoss® Bone Graft Substitute
Applicant
Stryker Spine
Product code
Product code MQV
Device class
Class 2
Regulation
21 CFR 888.3045
Advisory panel
Orthopedic
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Allendale, NJ, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code MQV

view all

More clearances from Stryker Spine

view all

Adverse events under product code MQV

product code MQV
Death
6
Injury
435
Total
441

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.